Cabaletta Bio, Inc.
CABA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $40 | $38 | $29 | $26 |
| G&A Expenses | $7 | $0 | $0 | $0 |
| SG&A Expenses | $7 | $8 | $8 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $46 | $45 | $37 | $33 |
| Operating Income | -$47 | -$46 | -$37 | -$34 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | $1 | $1 | $1 |
| Pre-Tax Income | -$45 | -$45 | -$36 | -$33 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$45 | -$45 | -$36 | -$33 |
| % Margin | – | – | – | – |
| EPS | -0.44 | -0.73 | -0.73 | -0.65 |
| % Growth | 39.7% | 0% | -12.3% | – |
| EPS Diluted | -0.44 | -0.73 | -0.73 | -0.65 |
| Weighted Avg Shares Out | 102 | 62 | 50 | 50 |
| Weighted Avg Shares Out Dil | 102 | 62 | 49 | 50 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $2 |
| Interest Expense | $1 | $1 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$44 | -$44 | -$35 | -$31 |
| % Margin | – | – | – | – |